Limei Ai

420 total citations
24 papers, 305 citations indexed

About

Limei Ai is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Limei Ai has authored 24 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Hematology. Recurrent topics in Limei Ai's work include CRISPR and Genetic Engineering (3 papers), Acute Myeloid Leukemia Research (2 papers) and CAR-T cell therapy research (2 papers). Limei Ai is often cited by papers focused on CRISPR and Genetic Engineering (3 papers), Acute Myeloid Leukemia Research (2 papers) and CAR-T cell therapy research (2 papers). Limei Ai collaborates with scholars based in China, United States and Hong Kong. Limei Ai's co-authors include Shanshan Yu, Wei Sun, Wei Wei, Yang Yu, Ning Zhang, Wei Wei, Yuanyuan Sun, Shanshan Yu, Jing Pan and Jing Pan and has published in prestigious journals such as Advanced Functional Materials, Scientific Reports and Journal of Cellular Physiology.

In The Last Decade

Limei Ai

23 papers receiving 299 citations

Peers

Limei Ai
Chengxin Luo China
Chansu Lee South Korea
Lucy C.J. Ellis United Kingdom
Vahid Niazi Iran
Tingbo Liu China
Xiaoling Yu China
Kwang-Sung Ahn South Korea
Chengxin Luo China
Limei Ai
Citations per year, relative to Limei Ai Limei Ai (= 1×) peers Chengxin Luo

Countries citing papers authored by Limei Ai

Since Specialization
Citations

This map shows the geographic impact of Limei Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limei Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limei Ai more than expected).

Fields of papers citing papers by Limei Ai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Limei Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limei Ai. The network helps show where Limei Ai may publish in the future.

Co-authorship network of co-authors of Limei Ai

This figure shows the co-authorship network connecting the top 25 collaborators of Limei Ai. A scholar is included among the top collaborators of Limei Ai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Limei Ai. Limei Ai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ai, Liqing, Weikang Lin, Limei Ai, et al.. (2025). “Heat‐Press‐N‐Go” Stretchable Interconnects Enabled by Liquid Metal Conductor with Supramolecular Confinement. Advanced Functional Materials. 35(20). 7 indexed citations
2.
Yu, Miao, Limei Ai, Bang Wang, et al.. (2025). GenomePAM directs PAM characterization and engineering of CRISPR-Cas nucleases using mammalian genome repeats. Nature Biomedical Engineering. 10(2). 231–244. 1 indexed citations
3.
4.
Lu, Chenyu, Fugui Li, Limei Ai, et al.. (2024). Circulating DNA genome-wide fragmentation in early detection and disease monitoring of hepatocellular carcinoma. iScience. 27(5). 109701–109701. 2 indexed citations
5.
Zhang, Jiayi, et al.. (2024). Identification of ferroptosis-related genes associated with diffuse large B-cell lymphoma via bioinformatics and machine learning approaches. International Journal of Biological Macromolecules. 282(Pt 3). 137117–137117. 6 indexed citations
6.
Wang, Baohua, et al.. (2023). Optimal Look-Back Period to Identify True Incident Cases of Diabetes in Medical Insurance Data in the Chinese Population: Retrospective Analysis Study. JMIR Public Health and Surveillance. 9. e46708–e46708. 1 indexed citations
7.
Geng, Mengxin, Limei Ai, Ming Ma, et al.. (2022). A DasA family sugar binding protein Ste2 links nutrient and oxidative stress to exopolysaccharides production in Streptomyces sp. 139. BMC Microbiology. 22(1). 69–69. 4 indexed citations
8.
Yu, Shanshan, et al.. (2020). circRNA circ-MYBL2 is a novel tumor suppressor and potential biomarker in multiple myeloma. Human Cell. 34(1). 219–228. 25 indexed citations
9.
Ai, Limei, Weiwei Guo, Wei Chen, Yun Teng, & Liping Bai. (2019). The gal80 Deletion by CRISPR-Cas9 in Engineered Saccharomyces cerevisiae Produces Artemisinic Acid Without Galactose Induction. Current Microbiology. 76(11). 1313–1319. 6 indexed citations
10.
Ai, Limei, et al.. (2019). Specific PCR method for detection of species origin in biochemical drugs via primers for the ATPase 8 gene by electrophoresis. Microchimica Acta. 186(9). 634–634. 5 indexed citations
11.
Ai, Limei, Mengxin Geng, Ming Ma, & Liping Bai. (2019). Complete Genome Sequence of the Ebosin-Producing Strain Streptomyces sp. 139. Microbiology Resource Announcements. 8(49). 2 indexed citations
12.
Sun, Yuanyuan, Jing Pan, Ning Zhang, et al.. (2017). Knockdown of long non-coding RNA H19 inhibits multiple myeloma cell growth via NF-κB pathway. Scientific Reports. 7(1). 18079–18079. 54 indexed citations
13.
Pan, Jing, Yuanyuan Sun, Ning Zhang, et al.. (2017). Characteristics of BAFF and APRIL factor expression in multiple myeloma and clinical significance. Oncology Letters. 14(3). 2657–2662. 25 indexed citations
14.
Wei, Wei, Wei Sun, Shanshan Yu, Yang Yu, & Limei Ai. (2016). Butyrate production from high-fiber diet protects against lymphoma tumor. Leukemia & lymphoma. 57(10). 2401–2408. 69 indexed citations
15.
Bai, Jie, et al.. (2015). Incidence and risk factors for myelofibrotic transformation among 272 Chinese patients with JAK2‐mutated polycythemia vera. American Journal of Hematology. 90(12). 1116–1121. 14 indexed citations
16.
Yang, Wenqing, et al.. (2015). Transforming growth factor β type II receptor as a marker in diffuse large B cell lymphoma. Tumor Biology. 36(12). 9903–9908. 6 indexed citations
17.
Bai, Jie, Hui Shi, Limei Ai, et al.. (2015). [Survival and prognosis of patients with polycythemia vera: a study of 816 patients in a single Chinese center].. PubMed. 95(18). 1364–8. 2 indexed citations
18.
Li, Bin, Jian Zhang, Lei Wang, et al.. (2013). MTHFR genetic polymorphisms may contribute to the risk of chronic myelogenous leukemia in adults: a meta-analysis of 12 genetic association studies. Tumor Biology. 35(5). 4233–4245. 8 indexed citations
19.
Ai, Limei, Liangliang Zhu, Yang Lü, et al.. (2013). Selectivity for inhibition of nilotinib on the catalytic activity of human UDP-glucuronosyltransferases. Xenobiotica. 44(4). 320–325. 52 indexed citations
20.
Ai, Limei, et al.. (2008). Enhancement of anti-lymphoma immuno-effects mediated by dendritic cells pulsed with heat-stressed and rituximab-coated CD20+ lymphoma cells. International Journal of Hematology. 87(5). 459–466. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengxin Luo Breakdown of academic impact, for papers by Chansu Lee Breakdown of academic impact, for papers by Lucy C.J. Ellis Breakdown of academic impact, for papers by Vahid Niazi Breakdown of academic impact, for papers by Tingbo Liu Breakdown of academic impact, for papers by Xiaoling Yu Breakdown of academic impact, for papers by Kwang-Sung Ahn
Rankless by CCL
2026